0 NASDAQ Companies - November 18, 2024REE Automotive to Report Third Quarter 2024 Financial Results on December 17, 2024TEL AVIV, Israel, Nov. 18, 2024 (GLOBE NEWSWIRE) — REE Automotive Ltd. (Nasdaq: REE), an automotive technology company and provider […]Read More
0 NYSE Companies - November 18, 2024Apollo Funds Acquire Majority Stake in The State Group, A Leading Provider of Multi-Trade ServicesNEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that funds associated with its Impact and […]Read More
0 TSX Venture News - November 18, 2024Start of Pilot-Scale Production Trials and Agreement to Supply Samples to Two Potential CustomersMONTRÉAL, Nov. 18, 2024 (GLOBE NEWSWIRE) — NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud […]Read More
0 NYSE Companies - November 18, 2024Coherent Launches High-Speed Photodiodes for 1.6T TransceiversPITTSBURGH, Nov. 18, 2024 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in high-performance optical networking solutions, has […]Read More
0 NASDAQ Companies - November 18, 20245E Advanced Materials to Host Investor Update Conference Call Post First Quarter 2025 Earnings ReleaseHESPERIA, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), […]Read More
0 NYSE Companies - November 18, 2024Armada Hoffler’s Board of Directors Names Shawn Tibbetts as Chief Executive Officer Effective January 1, 2025VIRGINIA BEACH, Va., Nov. 18, 2024 (GLOBE NEWSWIRE) — Armada Hoffler’s (NYSE: AHH) Board of Directors announces that Shawn Tibbetts, […]Read More
0 NASDAQ Companies - November 18, 2024NWTN Receives Nasdaq Staff Delisting Determination for Non-Compliance with Listing Rule 5250(c)(1)DUBAI, United Arab Emirates, Nov. 18, 2024 (GLOBE NEWSWIRE) — NWTN Inc. (Nasdaq: NWTN), an eco-conscious mobility technology company bringing […]Read More
0 NASDAQ Companies - November 18, 2024Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of DirectorsFOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage […]Read More